← back to search

Claire M. Steppan

Pfizer (United States) · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Adipokines, Inflammation, and Metabolic Diseases, Adipose Tissue and Metabolism, and COVID-19 Clinical Research Studies.
h-index
36
citations
13,814
works
69
NIH funding
—
primary concept
Chemistry
email
claire.m.steppan@pfizer.com

Recent publications

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Nature Communications 2021cited by 293position: middledoi
A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL <sup>pro</sup> Inhibitor PF-00835231 as a Potential New Treatment for COVID-19
Journal of Virology 2021cited by 142position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alberto Herrera · Cornell University1 papers (2021–2021)Ana Mayela Valero Jimenez · New York University1 papers (2021–2021)Austin R. Schinlever · New York University1 papers (2021–2021)Adil Mohamed · New York University1 papers (2021–2021)Kelly V. Ruggles · NYU Langone Health1 papers (2021–2021)Meike Dittmann · New York University1 papers (2021–2021)Joseph C. Devlin · Regeneron (United States)1 papers (2021–2021)Maren de Vries · New York University1 papers (2021–2021)Ellie Ivanova · New York University1 papers (2021–2021)Rachel A. Prescott · New York University1 papers (2021–2021)Sergei B. Koralov · New York University1 papers (2021–2021)— · 1 papers (2021–2021)— · 1 papers (2021–2021)Ludovic Desvignes · New York University1 papers (2021–2021)Annaliesa S. Anderson · Pfizer (United States)1 papers (2021–2021)Paige Loose · New York University1 papers (2021–2021)